【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cutaneous T-Cell Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cutaneous T-Cell Lymphoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cutaneous T-Cell Lymphoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cutaneous T-Cell Lymphoma 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on Cutaneous T-Cell Lymphoma 36
Jan 15, 2014: Addition of Japanese Sites for Pivotal Phase 3 Trial of Mogamulizumab in Patients with Cutaneous T-Cell Lymphoma 36
Oct 08, 2013: OncoSec Medical Announces Positive Preliminary Safety Data in Combination Study 36
Jul 24, 2013: Inovio Pharmaceuticals’ Potent hTERT DNA Cancer Vaccine Shows Potential to Reduce Tumors and Prevent Tumor Recurrence 37
Dec 13, 2012: Kyowa Hakko Kirin Initiates Pivotal Phase III Trial Of Mogamulizumab In Patients With Cutaneous T-Cell Lymphoma In US 38
Dec 11, 2012: Kyowa Hakko Kirin Announces Presentation Of Phase II Clinical Trial Results Of Mogamulizumab At ASH Annual Meeting 38
Clinical Trial Profiles 40
Clinical Trial Overview of Top Companies 40
Merck & Co., Inc. 40
Clinical Trial Overview of Merck & Co., Inc. 40
Novartis AG 41
Clinical Trial Overview of Novartis AG 41
Ligand Pharmaceuticals, Inc. 42
Clinical Trial Overview of Ligand Pharmaceuticals, Inc. 42
Eisai Co., Ltd. 43
Clinical Trial Overview of Eisai Co., Ltd. 43
Celgene Corporation 44
Clinical Trial Overview of Celgene Corporation 44
BioCryst Pharmaceuticals, Inc. 45
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 45
Takeda Pharmaceutical Company Limited 46
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 46
Kirin Holdings Company, Limited 47
Clinical Trial Overview of Kirin Holdings Company, Limited 47
Emergent BioSolutions Inc. 48
Clinical Trial Overview of Emergent BioSolutions Inc. 48
Eli Lilly and Company 49
Clinical Trial Overview of Eli Lilly and Company 49
Clinical Trial Overview of Top Institutes / Government 50
National Cancer Institute 50
Clinical Trial Overview of National Cancer Institute 50
Fred Hutchinson Cancer Research Center 53
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 53
The University of Texas M. D. Anderson Cancer Center 55
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 55
Northwestern University 56
Clinical Trial Overview of Northwestern University 56
Stanford University 57
Clinical Trial Overview of Stanford University 57
University of Washington 58
Clinical Trial Overview of University of Washington 58
Memorial Sloan Kettering Cancer Center 59
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 59
European Organization for Research and Treatment of Cancer 60
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 60
Case Comprehensive Cancer Center 61
Clinical Trial Overview of Case Comprehensive Cancer Center 61
Mayo Clinic 62
Clinical Trial Overview of Mayo Clinic 62
Five Key Clinical Profiles 63
Appendix 115
Abbreviations 115
Definitions 115
Research Methodology 116
Secondary Research 116
About GlobalData 117
Contact Us 117
Disclaimer 117
Source 118
【レポート販売概要】
■ タイトル：皮膚T細胞リンパ腫：世界の臨床試験レビュー（2014年上半期）■ 英文：Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014
■ 発行日：2014年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDHC2011CTIDB
■ 調査対象地域：グローバル
- 2014年戦略提言：イギリスの血液凝固検査市場Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.SummaryThis comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market during the next five years. The report explores business and technologic …
- 高等教育Mラーニングの世界市場2016-2020About M-learning Students increasingly using smartphones and tablets for study purposes is the primary factor driving the growth of the m-learning market. However, to include m-learning as a part of the curriculum learning process, educational institutions must have a strong ICT infrastructure. For this, these establishments need to invest heavily in installing software and enhancing server capabi …
- 世界のサプライチェーン分析：LCDテレビ市場The worldwide LCD TV industry has entered the maturity phase, with shipments slowing down in recent years. However, bolstered by the 2014 FIFA World Cup, global LCD TV sales reached around 208 million units in 2014, up 4.2% year on year. This report profiles the worldwide and Taiwanese LCD TV markets, investigates into development trends of different products, including 3D TV, smart TV, and 4K TV, …
- グローバル電力市場におけるトップ10企業分析Synopsis The ICD Research Global Top 10 Power Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global power industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. State Grid Corporation of China E.ON SE GDF Suez SA Enel S.p …
- 患者ポータルの世界市場予測（～2020）The global patient portal market is segmented on the basis of type, delivery mode, and end user. The market is expected to reach USD 2.74 Billion in 2020 from USD 1.19 Billion in 2015, growing at a CAGR of 18.1%. The market is expected to be dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The European region is expected to grow at the highest rate dur …
- 液化石油ガス（LPG）の世界市場Liquid Petroleum Gas can be segmented by Usages, Services, Companies and Equipment. Usages of this market are Upstream - Oil & Gas. Services of this market are Well Intervention, Drilling Services and Production Services - Oilfield. Companies of this market are Saudi Aramco, Exxon Mobil Corp, BP Global, National Iranian Oil Company, Royal Dutch Shell plc, Chevron Corporation, Other Companies, Chin …
- ヒトインスリンの世界市場：ヒトインスリン薬、ヒトインスリン・デリバリーデバイスThe global human insulin market is poised to reach ~USD 39.13 Billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. Market growth can be attributed to factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery dev …
- 世界のカプノグラフィー市場動向（2012-2016）TechNavio's analysts forecast the Global Capnography market to grow at a CAGR of 20.17 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of portable capnographs. The market has also been witnessing increasing adoption of Microstream capnography. However, the lack of product differentiation could pose a challenge to the growth of …
- Gliosarcoma：グローバル臨床試験レビューH2, 2013Gliosarcoma Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Gliosarcoma Global Clinical Trials Review, H2, 2013" provides data on the Gliosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gliosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of …
- 臨床アラーム管理の世界市場予測（～2023年）The clinical alarm management market is projected to grow at a CAGR of 30.4% during the forecast period.The global clinical alarm management market is expected to reach 1,724 million by 2023 from an estimated USD 457 million in 2018, at a CAGR of 30.4% during the forecast period. Increasing alarm fatigue, high prevalence of chronic diseases, growth in the geriatric population, need for cost-contai …
- Melanoma：グローバル臨床試験レビューH1, 2013Melanoma Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, H1, 2013" provides data on the Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Melanoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- アメリカの妊婦向けパーソナルケア製品市場2016-2020About Personal Care Products for Maternity Market In the US The personal care products for maternity market is a sub-segment of the overall personal care market based on product use by a specific target audience. This sub-segment includes six product categories: skin care, hair care, oral hygiene, bath, sun care, and depilatory products. BPC manufacturers focus on enhancing brand and brand recall …
- 食品安全性試験の世界市場：病原体（大腸菌、サルモネラ菌、カンピロバクター、リステリア）、殺虫剤、GMO、毒素The global food safety testing market has grown exponentially in the last few years. The market size is projected to reach USD 17.16 Billion by 2021, at a CAGR of around 7.4% from 2016. Increase in outbreaks of foodborne illnesses, globally; implementation of stringent food safety regulations; and globalization of food supply are the major driving factors for the market. The food safety testing ma …
- 学生情報システムの世界市場2015-2019Technavio’s market research analysts predict the global student information systems market to grow at a CAGR of over 12% in the next four years. Schools are implementing student information systems and software to simplify various processes and connectivity among departments. With rising penetration of technology in education, educators are expanding their services in multiple areas such as blende …
- 肩撃ち式兵器の世界市場2019-2023About this market The evolution of battlefield environment necessitated the subsequent upgrade and customization of armament. Currently, the US Marine Corps are engaged in testing the new version of the M72 shoulder-fired single usage rocket launcher. Depending on the type of rocket inside the prepackaged launcher, and at its heaviest configuration, it is three pounds lighter than a shoulder-fired …
